BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 9803343)

  • 1. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
    Krediet RT
    Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of peritoneal dialysis on peritoneal morphology.
    Dobbie JW; Anderson JD; Hind C
    Perit Dial Int; 1994; 14 Suppl 3():S16-20. PubMed ID: 7948267
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical research in peritoneal dialysis.
    Coles GA
    Contrib Nephrol; 2001; (131):125-31. PubMed ID: 11125558
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical morphological approach to simple peritoneal sclerosis.
    Di Paolo N; Gaggiotti E
    Int J Artif Organs; 2005 Feb; 28(2):85-9. PubMed ID: 15770595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane viability in the long-term peritoneal dialysis patient.
    Schreiber MJ
    Perit Dial Int; 1997; 17 Suppl 3():S19-24. PubMed ID: 9304652
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
    Feriani M
    Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
    [No Abstract]   [Full Text] [Related]  

  • 8. A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects.
    Cappelli G; Amore A; Bandiani G; Cancarini G; Coppo R; Feriani M; Dell'Aquila R; Saffioti S; Spisni C; Stingone A; Orazi E; Ballocchi S; Renaux JL
    Contrib Nephrol; 2001; (131):97-106. PubMed ID: 11125568
    [No Abstract]   [Full Text] [Related]  

  • 9. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
    Park MS; Lee HB
    Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solution.
    Yokoyama K; Matsuo N; Yoshida H; Sherif AM; Yaginuma T; Yamamoto H; Kawakami M; Hosoya T
    Kidney Int; 2008 Sep; 74(6):822. PubMed ID: 18756296
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis.
    Witowski J; Ksiazek K; Jörres A
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S34-7. PubMed ID: 19008538
    [No Abstract]   [Full Text] [Related]  

  • 13. Biocompatibility of peritoneal dialysis treatment.
    Di Paolo N; Garosi G; Monaci G; Brardi S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():78-83. PubMed ID: 9075235
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of biocompatibility in peritoneal dialysis solutions.
    Passlick-Deetjen J
    Perit Dial Int; 1993; 13 Suppl 2():S101-4. PubMed ID: 8399540
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent perspectives on peritoneal dialysis.
    Gokal R
    Contrib Nephrol; 1993; 102():98-109. PubMed ID: 8416191
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morpho-functional study of peritoneum in peritoneal dialysis].
    Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
    G Ital Nefrol; 2003; 20(2):160-5. PubMed ID: 12746801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfotanshinone IIA Sodium Ameliorates Glucose Peritoneal Dialysis Solution-Induced Human Peritoneal Mesothelial Cell Injury via Suppression of ASK1-P38-mediated Oxidative Stress.
    Zhou Y; He W; Sun W; Zhou Z; Sun M; Xia P; Li W; Zheng M; Zhang L; Ni J; Gao K
    Cell Physiol Biochem; 2018; 46(6):2434-2444. PubMed ID: 29742502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis.
    Gambaro G; Weigert C; Ceol M; Schleicher ED
    Contrib Nephrol; 2001; (131):107-13. PubMed ID: 11125556
    [No Abstract]   [Full Text] [Related]  

  • 19. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APD schedules and clinical results.
    Durand PY
    Contrib Nephrol; 2003; (140):272-7. PubMed ID: 12800369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.